According to Dynavax Technologies 's latest financial reports the company's total debt is $0.25 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.25 B | -0.42% |
2022-12-31 | $0.25 B | 0.24% |
2021-12-31 | $0.25 B | 18.15% |
2020-12-31 | $0.21 B | 0.65% |
2019-12-31 | $0.21 B | 114.58% |
2018-12-31 | $0.10 B | |
2014-12-31 | $9.55 M | |
2012-12-31 | $N/A | -100% |
2011-12-31 | $12.81 M | 8.73% |
2010-12-31 | $11.78 M | -4.85% |
2009-12-31 | $12.38 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $70.84 B | 27,475.38% | ๐บ๐ธ USA |
Amgen AMGN | $64.61 B | 25,049.66% | ๐บ๐ธ USA |
Biogen BIIB | $7.33 B | 2,756.29% | ๐บ๐ธ USA |
Gilead Sciences GILD | $24.98 B | 9,625.82% | ๐บ๐ธ USA |
Merck MRK | $35.05 B | 13,544.64% | ๐บ๐ธ USA |
AstraZeneca AZN | $28.62 B | 11,040.69% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $22.93 B | 8,827.85% | ๐ฌ๐ง UK |
Agenus
AGEN | $78.01 M | -69.63% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $20.15 B | 7,744.26% | ๐ฎ๐ฑ Israel |